Novo Nordisk's pricing tactics inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of selling price gouging, pointing out the stark contrast involving U.S. rates and those in Europe and copyright.This led Novo Nordisk to conduct further more investigate into higher dosages of semaglutide speci